Related Experiment Video
Updated: May 16, 2026
11:27
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
[Proposed alternative to standard apomorphine challenge test].
Juan Carlos Martínez-Castrillo1, Juan Andrés Burguera
1Hospital Universitario Ramon y Cajal, 28034 Madrid, Espana.
Revista De Neurologia
|November 22, 2012
Summary
This study proposes a faster apomorphine challenge test for Parkinson's disease patients. A single, higher dose injection can streamline treatment planning and reduce patient wait times.
Area of Science:
- Neurology
- Pharmacology
Background:
- Subcutaneous apomorphine injection is a rescue treatment for Parkinson's disease (PD) off-periods.
- It is also used to assess dopaminergic response but is less specific and has more side effects than levodopa.
- Current apomorphine challenge tests for dosage calculation are time-consuming, involving multiple dose testing.
Purpose of the Study:
- To propose an alternative, time-efficient apomorphine challenge test for Parkinson's disease.
- To establish a method for scheduling treatment based on a single, higher-dose apomorphine injection.
Main Methods:
- An alternative apomorphine challenge test using a single injection with an initial dosage of 2-4 mg.
- Scheduling treatment based on the patient's response to this single dosage.
Main Results:
- The proposed method significantly reduces the time required for the apomorphine challenge test.
- It allows for more efficient planning of medical attention for Parkinson's disease patients.
Conclusions:
- The single, higher-dose apomorphine challenge test offers a time-saving alternative to traditional methods.
- This streamlined approach can improve the management and treatment planning for individuals with Parkinson's disease.
